CD34 expression in glioblastoma and giant cell glioblastoma

Clinical Neuropathology

Volumn 29, Issue 2, 2010, Pages 89-93

  Galloway, M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

CD34; Giant cell glioblastoma; Glioblastoma

Indexed keywords

CD34 ANTIGEN;

ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GIANT CELL TUMOR; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77950977729     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/npp29089     Document Type: Article

References (17)

1. Becker AJ, Wiestler OD, Figarella-Branger D, Blumcke I. Ganglioglioma and gangliocytoma. In: Louis DN, Ohgaki H, Wisteler OD, Cavanee WK (eds). WHO Classification of Tumours of the Central Nervous System. Lyon: World Health Organisation; 2007. p. 103-105.
2. Blumcke I, Lobach M, Wolf HK, Wiestler OD. Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumours. Micros Res Tech. 1999; 46: 53-58. (Pubitemid 29319278)
3. Chaubal A, Paetau A, Zoltick P, Miettinen M. CD34 immunoreactivity in nervous system tumours. Acta Neuropathol. 1994; 88: 454-458. (Pubitemid 2163195)
4. Cummings TJ, Burchette JL, McLendon RE. CD34 and dural fibroblasts: the relationship to solitary fibrous tumour and meningioma. Acta Neuropathol. 2001; 102: 349-354.
5. Fauser S, Becker A, Schulze-Bonhage A, Hildebrandt M, Tuxhorn I, Pannek HW, Lahl R, Schramm J, Blümcke I. CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol. 2004; 108: 272-278. (Pubitemid 39317694)
6. Hahn HP, Bundock EA, Hornick JL. Immunohistochemical staining for Claudin-1 can help distinguish meningiomas from histologic mimics. Am J Clin Pathol. 2006; 125: 203-208.
7. Giannini C, Paulus W, Louis DN, Liberski P. Pleomorphic xanthoastrocytoma. In: Louis DN, Ohgaki H, Wisteler OD, Cavanee WK (eds). WHO Classification of Tumours of the Central Nervous System. Lyon: World Health Organisation; 2007. p. 22-24.
8. Louis DN, Ohgaki H, Wisteler OD, Cavanee WK. WHO Classification of Tumours of the Central Nervous System. Lyon: World Health Organisation; 2007.
9. Kleihues P, Burger PC, Aldape KD, Brat DJ, Biernat W, Bigner DD, Nakazato Y, Plate KH, Giangaspero F, von Deimling A, Ohgaki H, Cavanee WK. Glioblastoma. In: Louis DN, Ohgaki H, Wisteler OD, Cavanee WK (eds). WHO Classification of Tumours of the Central Nervous System. Lyon: World Health Organisation; 2007. p. 33-47.
10. Majores M, von Lehe M, Fasunke J, Schramm J, Becker AJ, Simon M. Tumor recurrence and malignant progression of gangliogliomas. Cancer. 2008; 113: 3355-3363.
11. Pasquier B, Peoch M, Morrison AL, Gay E, Pasquier D, Grand S, Sindou M, Kopp N. Chordoid glioma of the third ventricle: a report of two new cases, with further evidence supporting an ependymal differentiation, and review of the literature. Am J Surg Pathol. 2002; 26: 1330-1342.
12. Pasquier B, Peoch M, Fabre-Bocquentin B, Bensaadi L, Pasquier D, Hoffmann D, Kahane P, Tassi L, Le Bas J-F, Louis Benabid A. Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections. Epileptic Disord. 2002; 4: 99-119.
13. Prayson RA, McMahon JT, Barnett GH. Solitary fibrous tumor of the meninges. J Neurosurg. 1997; 86: 1049-1052.
14. Reifenberger G, Kaulich K, Wiestler OD. Expression of the CD34 antigen in pleomorphic xanthoastrocytoma. Acta Neuropathol. 2003; 105: 358-364. (Pubitemid 36798830)
15. Sisodiya SM, Fauser S, Cross JH, Thom M. Focal cortical dysplasia Type II: biological features and clinical perspectives. Lancet Neurology. 2009; 8: 830-843.
16. Tardio JC. CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions. J Cutan Pathol. 2009; 36: 89-102.
17. Yue WY, Chen ZP. Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem. 2005; 53: 997-1002.